BMY vs REED · P/E 17, rev $24.46B vs rev $7.5M
Bristol-Myers Squibb Company (BMY) versus Reed's, Inc. (REED) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Reed's, Inc. (REED) is a beverages - non-alcoholic company listed on AMEX.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported REED revenue for 2026-06-30 was $7.5M. Net income was -$4.3M. Revenue was up 4.8% from 2026-03-31 to 2026-06-30. REED currently screens at market cap $17.2M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. REED currently screens at market cap $17.2M.
Not investment advice. Open the BMY and REED stock pages for the full models.
Not investment advice.